Sophie CHOPINET

Dr. Sophie CHOPINET


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2017 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
SCSophie CHOPINET
Sophie CHOPINET
DFDavid Fuks
David Fuks
MRMathieu Rinaudo
Mathieu Rinaudo
JMJulien Massol
Julien Massol
EGEmilie Gregoire
Emilie Gregoire
BGBrice Gayet
Brice Gayet

30 November 2021 in Annals of Hepato-Biliary-Pancreatic Surgery
Verified
Journal Article
Open access
PDF file
VMValentine Martin
Valentine Martin
EGEmilie Gregoire
Emilie Gregoire
SCSophie CHOPINET
Sophie CHOPINET
OSOlivier Scatton
Olivier Scatton
RDRémi Dubois
Rémi Dubois
OBOlivier Boillot
Olivier Boillot
Valentine Martin, Emilie Gregoire, Sophie Chopinet, Olivier Scatton, Rémi Dubois, Antoinette Lasseur, Jérôme Dumortier, Olivier Boillot. Ann Hepatobiliary Pancreat Surg 2021;25:462-71. https://doi.org/10.14701/ahbps.2021.25.4.462

1 March 2019 in HPB
Verified
Journal Article
Closed access
SCSophie CHOPINET
Sophie CHOPINET
EGEmilie Grégoire
Emilie Grégoire
EBEmilie Bollon
Emilie Bollon
JHJean-François Hak
Jean-François Hak
APAnaïs Palen
Anaïs Palen
YTYves-Patrice Le Treut
Yves-Patrice Le Treut

1 February 2022 in World Neurosurgery
Verified
Journal Article
Closed access
JHJean-François Hak
Jean-François Hak
PBPierre-Yves Borius
Pierre-Yves Borius
GSGiorgio Spatola
Giorgio Spatola
SCSophie CHOPINET
Sophie CHOPINET
BTBenoit Testud
Benoit Testud
JRJean Regis
Jean Regis

1 August 2021 in JHEP Reports
Verified
Journal Article
Open access
SCSophie CHOPINET
Sophie CHOPINET
FCFrançois Cauchy
François Cauchy
Christian HobeikaChristian Hobeika
Christian Hobeika
ABAurélie Beaufrère
Aurélie Beaufrère
NPNicolas Poté
Nicolas Poté
OSOlivier Soubrane
Olivier Soubrane
Malignant transformation of hepatocellular adenoma (MT-HCA) may occur in up to 5% of tumours. However, the prognostic value of this event remains poorly described. In this study, we aimed to analyse the long-term outcomes of patients undergoing liver resection (LR) for MT-HCA compared to those of patients resected for hepatocellular carcinoma (HCC) occurring on normal liver parenchyma (NP-HCC). This single-centre retrospective study included all patients who underwent LR for MT-HCA at Beaujon Hospital between 2001 and 2019. MT-HCAs were classified as small foci of malignant transformation HCA (SF-HCA) and as malignant HCA (M-HCA) in cases of predominant HCC foci. Recurrence-free survival (RFS) of MT-HCA was compared with that of NP-HCC after propensity score matching. Forty patients (24 men, 16 women) underwent LR for MT-HCA, including 23 with SF-HCA and 17 with M-HCA. Of these cases, 16/40 (40%) had β-catenin mutations, 19/40 (47.5%) were inflammatory, 1 was HNF1α-mutated HCA and 4 (10%) were unclassified HCA. Microvascular invasion (12% vs. 0%, p = 0.091) and satellite nodules (25% vs. 4%, p = 0.028) were more frequently observed in M-HCA than in SF-HCA. After a median follow-up of 67 months, 10 (25%) patients with MT-HCA had tumour recurrence, including 9 with M-HCA and 1 with SF-HCA (p = 0.007). M-HCA was linked to significantly poorer 1-, 3-, 5- and 10-year RFS rates than SF-HCA (76%, 63%, 39%, 37% vs. 100%, 100%, 100%, 91%, p = 0.003). Multivariate analysis showed that SF-HCA was independently associated with improved RFS (hazard ratio 0.064; 95% CI 0.008–0.519; p = 0.01). After propensity score matching, NP-HCC was associated with significantly poorer 1-, 3-, 5- and 10-year RFS rates than MT-HCA (p = 0.01). HCA with malignant transformation yields a better long-term prognosis than NP-HCC. Among MT-HCA, SF-HCA is associated with a better prognosis than M-HCA. The prognostic relevance of malignant transformation of hepatocellular adenoma (HCA) remains unknown. Thus, the aim of our study was to compare the outcomes of patients undergoing liver resection for malignant transformation to those of patients undergoing liver resection for hepatocellular carcinoma (HCC). The main long-term risk after resection for carcinoma is recurrence. In this study, 10/40 patients with malignant transformation of HCA relapsed after resection and we identified age >55 years, presence of satellite nodes, and microvascular invasion as risk factors for long-term recurrence. Compared to patients with HCC, patients who underwent liver resection for HCA with malignant transformation had better long-term survival.

1 May 2017 in Digestive and Liver Disease
Verified
Journal Article
Closed access
CDChristine Denet
Christine Denet
David FuksDavid Fuks
David Fuks
FCFrancesca Cocco
Francesca Cocco
SCSophie CHOPINET
Sophie CHOPINET
MAMarcel Abbas
Marcel Abbas
BGBrice Gayet
Brice Gayet